Delivery Order SPE2DB22D3301-SPE2DB24FY0VB
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $77,021.70 firm-fixed-price delivery order is for 4564450110 - BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of May 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of BIKTARVY 50-200-25 MG TABLET in quantities of 30s. The award, valued at $40,281.54, is a firm fixed-price delivery order contract issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of November 20, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award, valued at $97,140.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running through December 2025. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, to support military treatment...
- This federal contract award, valued at $18,150.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product BIKTARVY 50-200-25 MG TABLET UU 30S, with a performance period ending on March 1, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,159.67 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication. The contract has an ultimate completion date of September 21, 2023. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $18,205.34 firm fixed-price delivery order is for the pharmaceutical product BIKTARVY 50-200-25 MG TABLET. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc. that covers a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $36,024.18 for the supply of BIKTARVY 50-200-25 MG TABLET. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans'...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $68,493.14 delivery order contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of September 28, 2023 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $21,361.39 for the supply of Biktarvy 50-200-25 30S, a pharmaceutical product. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that supports the Department of Defense. The contract has an ultimate completion date of December 27, 2023 and is a firm fixed-price delivery order. Amerisourcebergen holds a larger Indefinite...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of BIKTARVY 50-200-25 MG TABLET to the Defense Logistics Agency (DLA). The award, valued at $97,947.83, is a Firm Fixed Price Delivery Order contract with a completion date of September 3, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is also registered as a federal contractor. The contract does not have a set-aside designation,...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY0VBDelivery Order
This federal contract award, valued at $77,205.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the medical product BIKTARVY 50-200-25 MG TABLET UU 30S. The award has an ultimate completion date of February 15, 2024, and a pricing type of Firm Fixed Price. Amerisourcebergen is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $77.2k | 2/14/24 |